"10.1371_journal.pone.0146905","plos one","2016-01-12T00:00:00Z","Katrina M Pollock; Damien J Montamat-Sicotte; Lisa Grass; Graham S Cooke; Moses S Kapembwa; Onn M Kon; Robert D Sampson; Graham P Taylor; Ajit Lalvani","Tuberculosis Research Centre, Respiratory Infections Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Section of Virology, Department of Medicine, Imperial College London, London, United Kingdom; Department of GU and HIV Medicine, The North West London Hospitals NHS Trust, London, United Kingdom; Tuberculosis Service, St Maryâ€™s Hospital, Imperial College Healthcare Trust, London, United Kingdom; Centre for Respiratory Infection, Flow Cytometry Facility, National Heart and Lung Institute, Imperial College London, London, United Kingdom","Conceived and designed the experiments: KP DMS AL. Performed the experiments: KP RS. Analyzed the data: KP DMS. Contributed reagents/materials/analysis tools: AL. Wrote the paper: KP GT AL. Assisted in recruitment and clinical stratification: OMK GC LG MK.","The ESAT-6/CFP-10 ELISpot was commercialised by an Oxford University spin-out company (Oxford Immunotec Ltd, Abingdon, UK) in which Oxford University and Professor Lalvani have a minority share of equity and entitlement to royalties. KMP GPT and AL are joint holders of a patent Novel TB diagnostic method WO2015/033136. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2016","01","Katrina M Pollock","KMP",9,TRUE,3,2,2,3,TRUE,TRUE,FALSE,0,NA,FALSE
